LaQuita M. Jones

Overcoming adaptive therapy resistance in AML by targeting immune response pathways

Katelyn Melgar, Morgan M. Walker, LaQuita M. Jones et al. · Science Translational Medicine · 2019 · 86 citations · Full text

“Pre-B” phenotypes in blast crisis of Ph1 positive CML: Evidence for a pluripotential stem cell “target”

Melvyn F. Greaves, Winston Verbi, B.R. Reeves et al. · Leukemia Research · 1979 · 70 citations

Lineage Plasticity, Induced Pluripotent Stem Cell, Developmental Biology +8

Clonality of chronic neutrophilic leukaemia associated with myeloma: analysis using the X-linked probe M27 beta.

Graham R. Standen, F. STEERS, LaQuita M. Jones · Journal of Clinical Pathology · 1993 · 51 citations · Full text

Targeting AML-associated FLT3 mutations with a type I kinase inhibitor

LaQuita M. Jones, Katelyn Melgar, Lyndsey Bolanos et al. · Journal of Clinical Investigation · 2020 · 35 citations · Full text

Mixed-phenotype Acute Leukemia, Aml-associated Flt3 Mutations, Flt3 Tkd +16

Reducing emergency department visits utilizing a primary care asthma specialty clinic in a high-risk patient population

Dane Snyder, Olivia Thomas, Sean Gleeson et al. · Journal of Asthma · 2017 · 19 citations